Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome-Reference-Cited by-同舟云学术

Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome

Published:2015-09 Issue: Volume:72 Page:16-24
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Santilli Francesca,Blardi Patrizia,Scapellato Carlo,Bocchia Monica,Guazzi Gianni,Terzuoli Lucia,Tabucchi Antonella,Silvietti Antonella,Lucani Benedetta,Gioffrè Walter Renato,Scarpini Francesca,Fazio Francesca,Davì Giovanni,Puccetti Luca

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference48 articles.

1. Nonalcoholic fatty liver disease;Angulo;N. Engl. J. Med.,2002

2. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications;Fabbrini;Hepatology,2010

3. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology;Chalasani;Gastroenterology,2012

4. Liver fat in the metabolic syndrome;Kotronen;J. Clin. Endocrinol. Metab.,2007

5. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease;Targher;N. Engl. J. Med.,2010

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lindera obtusiloba Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by Nε-(carboxymethyl)lysine;Nutrients;2024-07-19

2. Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review;Life;2024-04-04

3. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics;Prostaglandins & Other Lipid Mediators;2023-12

4. Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease;European Journal of Internal Medicine;2023-08

5. RAGE pathways play an important role in regulation of organ fibrosis;Life Sciences;2023-06